chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 25 minutes of receiving the vaccine, my left arm became very heavy and there was a tingling/neuro sensation in left wrist/hand. A pressure began in the  anterior of my throat which increased gradually. I sought treatment in our Urgent Care just after noon that same day. The Provider monitored my vitals which were good and administered liquid Pepcid. Said Provider chose not to give Benadryl as I had taken Zyrec that morning for my allergies. I was discharged from the Urgent Care and went back to work at 1245. At 1730 hours, I had a slight headache above my right eye and extreme right-sided jaw pain with tooth sensitivity. These lasted for only 10 minutes. At 1830, the anterior and bilateral portions of my throat began to feel "prickly" and I developed a wheeze. I used an albuterol inhaler to relieve the wheeze successfully. At this time I also developed an itchiness throughout my whole body, worse on left side than right side. I took 100mg of Benadryl with no relief. At 0300, I took another dose of 100mg of Benadryl with no relief. I also took an itch pill/antihistamine of my husband's which provided no relief. At 0800, I took 20 mg of Zyrtec. At 1030, I took 100mg of Benadryl. I continued to use Benadryl throughout the day, every 4-5 hours.  At 1800, I had a fullness in my throat, a tightness in my chest and my left shoulder blade felt almost numb.  I also had a hoarse voice which passed by the next morning. The chest tightness was intermittent over the next day or two.  On Friday, the itchiness had improved some but was still prominent. I continued to use Zyrtec and Benadryl throughout the day. My Primary Doctor called in Prednisone if needed. By Saturday morning, I felt MUCH better. Today is Sunday and I am no longer itching and I feel so much better today.
small amount of soreness at the injection site; This is a spontaneous report from a contactable consumer(patient)  A 82-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on 17Feb2021 at single dose for covid-19 immunisation .  The patient medical history was not reported. Concomitant medication included acetylsalicylic acid (ASPIRIN) taken for unspecified medical conditions, start and stop date were not reported.  The patient experienced small amount of soreness at the injection site on an unspecified date in 2021 with outcome of unknown.  Patient asked if it's okay to continue to take her Aspirin. No follow-up attempts are possible, information about batch number cannot be obtained.
I received my Covid 19 vaccine o12/06/2022. From 12/06/2022 until 12/24/2022 I felt really fatigue and had headache. On the night on the 24th I went to sleep and woke up having a seizure. I was rushed to the hospital on the 25th by ambulance and was diagnosed with low potassium. I
Rash, raised red covered mid (rt) arm, neck, torso, 20 hours later: local reaction 3 days with redness, swelling and hot to touch (rt) deltoid. Torso raise rash in 6 hours took BENADRYL (OTC) 50 mg q 6 hr. for 4 days. I took pics available put in pt's chart. 3rd day felt very fatigue came to office today.
Woke up the next morning with pain in my left shoulder.  Pain continued and increased since then.  Unable to raise arm, or move shoulder area without severe pain, and mobility is limited.
Very sore arm - Right after shot; lasted 3-4 days; Redness and welts - Hours after shot; lasted 4 days; Low-grade fever - Day after shot; lasted 1 day; Chills - Day after shot; lasted 1 day; Body aches - Day after shot; lasted 2 days Mild nausea - Day after shot; lasted 1 day; Fatigue - Day after shot; lasted 3-4 days; Headache - 5 days post-shot; lasted 1 day.
Narrative:  Other Relevant Hx: Symptoms:  & Tested positive for COVID Treatment:
This spontaneous report was received from a female patient of unknown age via company representative. The patient was reporting on herself. No pertinent medical history and drug reactions or allergies were reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, lot# and expiration date were not reported). Concomitant therapy was not provided. On an unknown date (reported as "after administration with ZOSTAVAX"), the patient experienced pain. The outcome of pain and the relatedness between pain and ZOSTAVAX were both not reported. Additional information has been requested.
Swelling of upper arm. Lower end of bicep up to shoulder. Wrapping from inside arm around the top of arm.
Product placed in refrigerator on 01 Mar 2022, after expiration; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Product placed in refrigerator on 01 Mar 2022, after expiration) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product placed in refrigerator on 01 Mar 2022, after expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Product placed in refrigerator on 01 Mar 2022, after expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  There was no temperature excursion. The reporter reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. Date the vial was placed in the refrigerator was on 01-Mar-2022.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
sores on her buttocks; This is a spontaneous report from a Pfizer Sponsored Program via contactable consumer or other non-health care professional (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration on 22Jan2021 as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sores on her buttocks on an unspecified date of 2021. Patient was prescribed Valacyclovir 500mg. Patient was wondering if she can take this in the middle of the vaccination series. The outcome of the event was unknown.     No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Chills, loss of appetite, head pressure when bending down, heavier breathing when walking, dizziness, needing to take a deeper breathe every once in awhile, and sore arm (injection area).
Pt received vaccinations at approximately 14:30 on 12/8/08. At 19:30, mom noticed multiple "hives" all on his body. No respiratory distress, fever, nausea, vomiting, diarrhea seen in clinic 12/09/08 AM, had multiple uticiaria lesions all over body. No respiratory distress.
Chills, sweating, nausea, muscle aches, weakness, feverish, SOB, arm painful (right), redness, swollen. Tylenol, Benadryl 50 mg as Per ER phone call.
Injection site stung and itched all day. Following morning 9/16/2015 woke up with hives lasting the two following days. 9/17/2015 saw doctor and was put on Benadryl and a steroid for 5 days.
Patient tested COVID positive following completion of COVID vaccine series. 02/03 COVID vaccine dose #1 02/24 COVID vaccine does #2 04/12 COVID tested due to exposure to someone with COVID, tested COVID positive, no symptoms 04/13 reports intermittent cough, runny nose, intermittent headache 04/14 reports congestion, runny nose, myalgia 04/15 reports congestion, ongoing will treat with otc meds 04/17 reports cough is nearly resolved, denies fatigue or SOP 04/18 asymptomatic.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPERSENSITIVITY (sensitivity at the injection site) and MYALGIA (very mild aching) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history reported.  Concomitant products included FLOMAX (FLOMAX URINATE) for Urination difficulty. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE HYPERSENSITIVITY (sensitivity at the injection site) and MYALGIA (very mild aching). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 01-Feb-2021, VACCINATION SITE HYPERSENSITIVITY (sensitivity at the injection site) and MYALGIA (very mild aching) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact.
Pain on the left arm and then I started having chills. Around 9:30PM I started having fever of 103 and my whole body was trembling. I took ibuprofen and went to sleep, I woke up several times during my sleep. When I woke up at 10AM my fever was 104, I tried eating but I did not have any taste. Today, I took 2 pills of acetaminophen and I am waiting for the reaction, I feel dizzy.
pt exposed to sibling & devel chickenpox consisting of about 40 pox;pt seen by MD tx w/acyclovir;
No additional information was provided regarding if the consumer experienced any side effects; PNEUMOVAX 23 was administered on 23 NOV 2020 after the excursion occurred; This spontaneous report was received from a registered nurse and refers to a 55-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 23-NOV-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection in prefilled syringe, lot # T022294, expiration date: 26-MAR-2022, 1 time dose (injection site and route of administration were not provided) for prophylaxis.  The administered vaccine had experienced a temperature excursion of above 9 degrees Celsius (C) (13.5 C) for 3 hours. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T022294; expirationdate: 26-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
The patient experienced a 3 minute episode of muscular tonic clonic movement, cyanosis and starring the morning after vaccination. The patient was referred to a pediatric neurologist.
Mild swelling 3" below (LA) medially & slightly warm to touch. Seen in f/u on 5-9-11 & redness spread from elbow, distally to wrist of left arm. Rx'd with KEFLEX & had extremity US done r/o clot. US normal, no DVT.
Acute hemolytic anemia, picked up on lab testing, asymptomatic, no treatment, spontaneous resolution.
On 06Nov2021 patient presented with sore throat and tested positive following covid-19 test.; On 06Nov2021 patient presented with sore throat and tested positive following covid-19 test.; Adverse event: On 06Nov2021 patient presented with sore throat and tested positive following covid-19 test.; This is a spontaneous report from a contactable consumer (Pfizer employee). A 12-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: Solution for injection, Lot Number: EW0185) via an unspecified route of administration on 02Jun2021 (age at vaccination 12 years-old) as single dose and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0169) via an unspecified route of administration on 11May2021 (age at vaccination 12 years-old) as single dose for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history and concomitant medications were not reported. Since the vaccination, the patient has tested for COVID-19. On 06Nov2021, patient experienced sore throat and tested positive following covid-19 test and vaccination failure. The patient underwent lab tests and procedures which included sars-cov-2 test and result was positive on 06Nov2021. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse refers to a male patient of unknown age. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot#, dose and route nor provided). Then patient had not received a document of previous dose of PNEUMOVAX 23 but it was reported that on an unspecified date, within the last 5 years, the patient was hospitalized for unspecified reasons and may have been vaccinated with PNEUMOVAX 23 (lot #, expiration date, dose and route not reported) during previous hospital stays. On an unknown date, directly after injection, the patient experienced injection site reactions which included swelling "to the size of grapefruits", redness and severe pain. The patient sought medical attention by office visit. The reactions were treated with unspecified steroids and antibiotics. The outcome of the unspecified reason why patient was hospitalized was unknown. The outcome of the events was reported as recovering. This is one of two reports received from the same source. Additional information has been requested.
Information has been received from a healthcare worker concerning a 25 year old female patient with no pertinent medical history and no known allergies who on an unspecified date was vaccinated with the first dose of GARDASIL (lot number not reported). The patient was new to the practice and the vaccine was not given in this practice. 2 days after the vaccination, the patient developed numbness to her left side. About 2 weeks after the onset of those symptoms, the patient was diagnosed with Multiple Sclerosis (MS). The patient saw family physician and neurologist (date unspecified). It was unknown if there were lab studies performed. At the time of the report, the outcome of the patient was not reported. Multiple sclerosis was considered to be disabling by the reporter. Follow-up information received from a medical assistant (MA) concerning the 23 year old (previously reported as 25 years old) female patient who on 19-FEB-2008 was vaccinated with the first dose of GARDASIL (lot number not reported). The MA did not know the physician's name where the patient received the vaccine. On 05-FEB-2009, the patient was first seen in the office for irregular bleeding. On MAR-2009 the patient was seen again and the irregular bleeding had resolved. Additional infoformation has been requested. 10/23/2009 records from Neurologist, multiple visits 3/2008-7/2009. Patient's sx started 2/2008 with numbness/tingling, inbalance, slurred speech, blurred vision and paralysis, LUE and LLE. PE noted hyperreflexia bilaterally, Romberg's sign absent. Dx MS
Pt. had seizure and passed out less than a minute. Pt. was very disoriented. Pt. doesn't remember what happened.
Shoulder pain beginning evening of injection. Muscle soreness at injection site. (4/11/2019) Lightheadedness that evening and very aware of my left arm including a numbness of two fingers on left hand. (4/12/2019) Overall feeling of weakness similar to flu symptoms but no fever. (4/11 to 4/13/ 2019) Much improved by (4/14/2019) however warm red rash at injection site.
This is the last dose of a 2-dose regimen; No additional AEs; This spontaneous report was received from a registered nurse referring to a female patient younger than 15 years old.   No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.   On 26-JUN-2020 and on 02-DEC-2020, the patient was vaccinated with doses 1 and 2 of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) respectively, for prophylaxis  (dose, route and site of administration, lot number and expiration date were not reported).  The nurse stated that this was the last dose of a 2-dose regimen (inappropriate schedule of product administration).  Nurse originally called in to inquire of an alternate dosing schedule for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No additional adverse events or product quality complains were reported.
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of unknown age and gender. There was no information on patients pertinent medical history and drug reactions or allergies. The healthcare worker reported that an unspecified number of patients received unspecified doses of improperly stored VAQTA, product lot# K005958, expiry date: 09-FEB-2017. No adverse effects were reported. There was no product quality complaint involved. The outcome of the events were unknown. This is one of the several reports from the same source. Additional information has been requested.
Hives, itching on torso - took benadryl capsule and symptoms dissipated
Patient complained of rash, redness at injection site and itchy all over. Mild rash noted on patient's chest as well.
A patient under the age of 18 received flublok with no reported adverse event; Initial information received on 27-Sep-2021 regarding an unsolicited valid non-serious case from a pharmacist via Media Information (under the reference 00787298).  This case involves an 11 years old female patient who received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] under the age of 18 (product administered to patient of inappropriate age).  The patient's past medical history, medical treatment(s), vaccination(s), Concomitant medication(s) and family history were not provided.  On 25-Sep-2021, the patient received a dose of suspect FLUBLOK QIV (0.5 ml, total, lot UJ723AA and expiration date: 30-jun-2022) via intramuscular route in the left arm for prophylactic vaccination.  It was an actual medication error due to vaccine administered to patient of inappropriate age.  At time of reporting, the outcome was unknown for the reported event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
On 2/2/2021 at about 1430 employee was at work complaining of feeling like her throat was closing . She also complained about chest tightness and shortness of breath. Co-workers took her to Nurse and she was placed on nasal cannula oxygen and and IV line was inserted while they awaited 911 EMS response. Employee was transferred to hospital and treated released to home from ER. Employee was discharged home with steroids and Albuterol  nebulizer. Employee stated that ER MD told her after reviewing CXR that her lungs showed inflammation and that she should not have received second vaccine dose. Employee states final ER diagnosis on 2.2.2021 stated Vaccine Adverse Reaction and Asthma Exacerbation.
My back hurts / your vaccine caused pain in my discs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (My back hurts / your vaccine caused pain in my discs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (My back hurts / your vaccine caused pain in my discs). At the time of the report, BACK PAIN (My back hurts / your vaccine caused pain in my discs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: This follow-up was received on 27-MAY-2021 which didn't update any new information.
Patient had previously received Janssen Covid-19 vaccine on 04/06/2021.  No current recommendation for booster doses or taking vaccine by additional different manufacturer
Right arm 11 1/2cm x 18 1/2cm redness without warmth.
got shot about 40 years ago, got sick and never got another flu shot and have never got sick from the flu; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 01-Dec-2020.  This case involves a patient of unknown demographics who got shot about 40 years ago, got sick and never got another flu shot and have never got sick from the flu (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got shot about 40 years ago, got sick and never got another flu shot and have never got sick from the flu (illness) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.